Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Data-sharing practices in publications funded by the Canadian Institutes of Health Research: implications for health sciences librarians.

The journal of the Canadian Health Libraries Association·2026
Same author

Personality Traits and Their Association With Falls and Fall-Related Psychological Concerns in Adults Aged 50 and Older: A Scoping Review.

Health science reports·2026
Same author

Association between life satisfaction and health behaviours among older adults: a systematic review and meta-analysis.

The international journal of behavioral nutrition and physical activity·2026
Same author

Association between sociodemographic factors and mobility among older adults: a systematic review and meta-analysis.

BMC geriatrics·2026
Same author

Co-occurrence of ipsilateral partial Horner's syndrome in a patient with monomelic amyotrophy.

BMJ case reports·2025
Same author

Association between life satisfaction and health behaviours among older adults: a systematic review and meta-analysis protocol.

BMJ open·2024

Related Experiment Video

Updated: May 23, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

Helicobacter pylori: Eradication or Preservation.

George Sachs1, David R Scott

  • 1Membrane Biology Laboratory, VA Greater Los Angeles Healthcare System West LA Medical Center, 11301 Wilshire Boulevard, Building 113, Room 324, Los Angeles, CA 90073 USA David Geffen School of Medicine, UCLA.

F1000 Medicine Reports
|April 14, 2012
PubMed
Summary

Helicobacter pylori infection causes gastritis, peptic ulcers, and gastric cancer in some individuals. However, this review examines the benefits and drawbacks of eradicating H. pylori in the general population using a "test and treat" strategy.

More Related Videos

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
04:56

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis

Published on: May 16, 2025

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
10:44

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode

Published on: June 18, 2016

Related Experiment Videos

Last Updated: May 23, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
04:56

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis

Published on: May 16, 2025

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
10:44

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode

Published on: June 18, 2016

Area of Science:

  • Gastroenterology
  • Microbiology
  • Public Health

Background:

  • * Helicobacter pylori infection is highly prevalent globally, affecting approximately 50% of the population.
  • * Infection is a primary cause of gastritis, with a subset developing peptic ulcer disease (10%) or gastric cancer (1%).
  • * Emerging evidence suggests potential protective roles of H. pylori against conditions like gastro-esophageal reflux disease and asthma.

Purpose of the Study:

  • * To critically evaluate the arguments for and against the widespread eradication of H. pylori.
  • * To assess the feasibility and implications of a "test and treat" approach for H. pylori infection in the general population.

Main Methods:

  • * This is a review article, synthesizing existing literature and research findings.
  • * Analysis of epidemiological data, clinical outcomes, and proposed benefits versus risks of eradication.
  • * Examination of the "test and treat" strategy in the context of public health.

Main Results:

  • * H. pylori eradication effectively resolves gastritis and prevents associated complications like ulcers and cancer.
  • * Potential negative consequences of eradication include an increased incidence of gastro-esophageal reflux disease and possibly asthma.
  • * The "test and treat" approach requires careful consideration of diagnostic accuracy, treatment efficacy, and long-term health impacts.

Conclusions:

  • * The decision to eradicate H. pylori requires balancing the prevention of severe gastrointestinal diseases against potential increases in other conditions.
  • * A universal "test and treat" strategy for H. pylori in the general population may not be universally beneficial and warrants further investigation.
  • * Individualized risk assessment and patient-centered care are crucial when considering H. pylori management.